多组分疫苗候选人 针对非类型的血型流感病毒
Nouria Belkacem1, Ala-Eddine Deghmane1, Muhamed-Kheir Taha1
1Institut Pasteur, Invasive Bacterial Infections Unit and National Reference Centre for Meningococci and Haemophilus influenzae, 75724 Paris Cedex 15, France.
Vaccines
|September 27, 2025
概括
针对非类型型的海莫菲勒斯流感 (NTHi) 的新疫苗显示出有前途. 蛋白质P5和P26具有免疫性,对小鼠的NTHi感染提供广泛的保护,为应对这种日益严重的公共卫生问题提供了潜在的战略.
科学领域:
- 细菌学和免疫学
- 疫苗开发 疫苗开发
- 基因组学和生物信息学
背景情况:
- 非类型型的Haemophilus influenzae (NTHi) 是一种普遍存在的格拉姆阴性细菌,导致局部和侵入性感染.
- 随着抗生素耐药性的增加,NTHi感染也在增加,缺乏有效的疫苗.
- 由于表面蛋白质的高变性,开发NTHi疫苗具有挑战性.
研究的目的:
- 为了确定NTHi的保护外膜蛋白 (OMP),用于疫苗开发.
- 评估两个特定的OMP,P5和P26.的疫苗潜力.
主要方法:
- 核心基因组多部位序列类型化 (cgMLST) 用于分析1144个Hi基因组.
- 确定了514个保存的OMP编码基因,重点是P5 (Haem1295) 和P26 (Haem1040).
- 蛋白质P5和P26被表达,净化,并测试在小鼠模型中进行主动和被动保护.
主要成果:
- 证实P5和P26在人类中具有免疫原性.
- 用P5和P26接种疫苗在小鼠中对NTHi给予了显著的保护.
- 该研究表明,对同源和异源NTHi菌株的广泛交叉保护.
结论:
- P5和P26是对NTHi的有希望的疫苗候选者.
- 这些蛋白质提供广泛的交叉保护,并向细菌毒性因素.
- 这些发现支持开发有效的NTHi疫苗.
相关概念视频
00:42Cross-reactivity
32.8K
Overview
32.8K
01:51Vaccinations
51.3K
Overview
51.3K
01:30Cancer Vaccines
972
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
972